UBS AM’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $528M | Sell |
2,224,578
-97,860
| -4% | -$20.3M | 0.1% | 171 |
|
|
2026
Q1 | $491M | Buy |
2,322,438
+8,625
| +0.4% | +$1.86M | 0.1% | 176 |
|
|
2025
Q4 | $475M | Sell |
2,313,813
-201,200
| -8% | -$37.9M | 0.1% | 166 |
|
|
2025
Q3 | $395M | Sell |
2,515,013
-65,613
| -3% | -$10.1M | 0.09% | 215 |
|
|
2025
Q2 | $434M | Buy |
2,580,626
+284,156
| +12% | +$42.2M | 0.09% | 221 |
|
|
2025
Q1 | $316M | Sell |
2,296,470
-25,327
| -1% | -$3.23M | 0.08% | 261 |
|
|
2024
Q4 | $275M | Buy |
2,321,797
+94,768
| +4% | +$11.1M | 0.06% | 277 |
|
|
2024
Q3 | $246M | Sell |
2,227,029
-243,035
| -10% | -$25.4M | 0.06% | 292 |
|
|
2024
Q2 | $243M | Buy |
2,470,064
+391,700
| +19% | +$39.9M | 0.07% | 257 |
|
|
2024
Q1 | $233M | Buy |
2,078,364
+213,880
| +11% | +$23.1M | 0.08% | 249 |
|
|
2023
Q4 | $188M | Sell |
1,864,484
-91,859
| -5% | -$9.11M | 0.07% | 273 |
|
|
2023
Q3 | $170M | Buy |
1,956,343
+155,469
| +9% | +$14.1M | 0.08% | 272 |
|
|
2023
Q2 | $136M | Hold |
1,800,874
| – | – | 0.07% | 324 |
|
|
2023
Q1 | $136M | Sell |
1,800,874
-168,947
| -9% | -$12.7M | 0.07% | 324 |
|
|
2022
Q4 | $151M | Buy |
1,969,821
+233,486
| +13% | +$17.7M | 0.08% | 283 |
|
|
2022
Q3 | $116M | Sell |
1,736,335
-124,727
| -7% | -$7.91M | 0.07% | 328 |
|
|
2022
Q2 | $97.3M | Sell |
1,861,062
-99,006
| -5% | -$5.63M | 0.05% | 384 |
|
|
2022
Q1 | $111M | Buy |
1,960,068
+141,158
| +8% | +$7.56M | 0.05% | 402 |
|
|
2021
Q4 | $93.7M | Buy |
1,818,910
+147,626
| +9% | +$7.24M | 0.04% | 486 |
|
|
2021
Q3 | $82.7M | Sell |
1,671,284
-74,113
| -4% | -$4.02M | 0.03% | 493 |
|
|
2021
Q2 | $99.6M | Sell |
1,745,397
-60,371
| -3% | -$3.53M | 0.04% | 435 |
|
|
2021
Q1 | $110M | Buy |
1,805,768
+110,367
| +7% | +$6.09M | 0.05% | 401 |
|
|
2020
Q4 | $90.8M | Sell |
1,695,401
-60,134
| -3% | -$3.12M | 0.04% | 435 |
|
|
2020
Q3 | $82.4M | Buy |
1,755,535
+16,674
| +1% | +$856K | 0.04% | 386 |
|
|
2020
Q2 | $90.8M | Sell |
1,738,861
-3,787
| -0.2% | -$195K | 0.06% | 331 |
|
|
2020
Q1 | $83.5M | Buy |
1,742,648
+176,823
| +11% | +$9.18M | 0.06% | 318 |
|
|
2019
Q4 | $79.2M | Buy |
1,565,825
+64,272
| +4% | +$3.32M | 0.05% | 399 |
|
|
2019
Q3 | $70.9M | Sell |
1,501,553
-201,846
| -12% | -$9.21M | 0.05% | 404 |
|
|
2019
Q2 | $80.2M | Buy |
1,703,399
+89,623
| +6% | +$4.13M | 0.06% | 364 |
|
|
2019
Q1 | $77.7M | Buy |
1,613,776
+135,395
| +9% | +$6.78M | 0.06% | 345 |
|
|
2018
Q4 | $65.9M | Buy |
1,478,381
+44,563
| +3% | +$2.32M | 0.06% | 363 |
|
|
2018
Q3 | $77.4M | Buy |
1,433,818
+108,653
| +8% | +$5.56M | 0.06% | 348 |
|
|
2018
Q2 | $64.7M | Sell |
1,325,165
-28,319
| -2% | -$1.61M | 0.05% | 407 |
|
|
2018
Q1 | $84.8M | Buy |
1,353,484
+179,079
| +15% | +$12.3M | 0.07% | 322 |
|
|
2017
Q4 | $72M | Buy |
1,174,405
+38,308
| +3% | +$2.37M | 0.06% | 343 |
|
|
2017
Q3 | $76M | Sell |
1,136,097
-272,954
| -19% | -$19.3M | 0.07% | 306 |
|
|
2017
Q2 | $110M | Buy |
1,409,051
+81,569
| +6% | +$6.16M | 0.11% | 225 |
|
|
2017
Q1 | $108M | Buy |
1,327,482
+33,332
| +3% | +$2.62M | 0.11% | 213 |
|
|
2016
Q4 | $93.1M | Sell |
1,294,150
-76,434
| -6% | -$5.53M | 0.1% | 220 |
|
|
2016
Q3 | $106M | Buy |
1,370,584
+230,169
| +20% | +$18.6M | 0.11% | 196 |
|
|
2016
Q2 | $89M | Buy |
1,140,415
+71,377
| +7% | +$5.69M | 0.1% | 222 |
|
|
2016
Q1 | $87.6M | Sell |
1,069,038
-214,272
| -17% | -$17.4M | 0.1% | 225 |
|
|
2015
Q4 | $115M | Sell |
1,283,310
-270,353
| -17% | -$23M | 0.13% | 173 |
|
|
2015
Q3 | $119M | Buy |
1,553,663
+146,550
| +10% | +$12.2M | 0.13% | 172 |
|
|
2015
Q2 | $118M | Sell |
1,407,113
-131,406
| -9% | -$11.6M | 0.11% | 203 |
|
|
2015
Q1 | $139M | Buy |
1,538,519
+111,192
| +8% | +$9.57M | 0.13% | 177 |
|
|
2014
Q4 | $115M | Buy |
1,427,327
+50,108
| +4% | +$3.96M | 0.11% | 214 |
|
|
2014
Q3 | $103M | Buy |
1,377,219
+65,538
| +5% | +$4.77M | 0.1% | 221 |
|
|
2014
Q2 | $89.9M | Sell |
1,311,681
-88,759
| -6% | -$6.04M | 0.09% | 255 |
|
|
2014
Q1 | $98M | Sell |
1,400,440
-478,390
| -25% | -$33.3M | 0.1% | 227 |
|
|
2013
Q4 | $126M | Sell |
1,878,830
-3,338,749
| -64% | -$204M | 0.14% | 173 |
|
|
2013
Q3 | $272M | Sell |
5,217,579
-1,117,502
| -18% | -$56.8M | 0.34% | 66 |
|
|
2013
Q2 | $299M | Buy |
+6,335,081
| New | +$289M | 0.39% | 58 |
|
Other funds holding CAH
UBS AM's CAH Position: Q2 2026 in Review
UBS AM reduced its Cardinal Health (CAH) stake by 4.2% in Q2 2026, selling an estimated $20.3M and leaving 2,224,578 shares worth $528M. The position accounts for 0.1% of the portfolio, ranked #171.
UBS AM first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- UBS AM held 2,224,578 shares of Cardinal Health worth $528M as of Q2 2026.
- UBS AM sold 97,860 Cardinal Health shares in Q2 2026, an estimated $20.3M.
- Cardinal Health made up 0.1% of UBS AM's portfolio in Q2 2026, its #171 holding.
- UBS AM first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
- 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.